¥379.00 ($2.40)

-3.00 (-0.79%)

Weekly Expected Move ±4.0%

¥352 ¥367 ¥382 ¥397 ¥412

JPX · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 38 · ¥37.5B mcap · 35M float · 0.969% daily turnover

Revenue

$49.2B +15.8% ▲

5Y CAGR: +39.9%

Gross Profit

$14.8B -13.3% ▼

5Y CAGR: +31.6%

Operating Income

$6.2B -41.9% ▼

5Y CAGR: +26.9%

Net Income

$3.7B -50.8% ▼

5Y CAGR: +24.2%

EPS (Diluted)

$37.51 -50.5% ▼

5Y CAGR: +22.7%

EBITDA

$8.9B -28.3% ▼

5Y CAGR: +32.7%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$15.3B	$23.1B	$32.0B	$42.5B	$49.2B
YoY Growth	+67.1%	+50.5%	+38.6%	+32.8%	+15.8%
Cost of Revenue	$9.0B	$13.4B	$18.7B	$25.4B	$34.4B
Gross Profit	$6.3B	$9.7B	$13.3B	$17.1B	$14.8B
Gross Margin	41.1%	42.0%	41.5%	40.2%	30.1%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$2.3B	$3.2B	$4.2B	$0	$7.8B
Operating Expenses	$2.5B	$3.6B	$4.6B	$6.4B	$8.6B
Operating Income	$3.8B	$6.1B	$8.6B	$10.6B	$6.2B
Operating Margin	24.7%	26.6%	27.0%	25.0%	12.5%
Interest Expense	$151M	$210M	$230M	$359M	$563M
Income Before Tax	$3.8B	$6.1B	$8.9B	$10.6B	$5.7B
Tax Expense	$1.2B	$1.8B	$2.6B	$3.1B	$2.0B
Net Income	$2.6B	$4.3B	$6.3B	$7.4B	$3.7B
Net Margin	17.1%	18.5%	19.7%	17.5%	7.4%
EPS (Diluted)	$27.51	$43.63	$64.32	$75.81	$37.51
EBITDA	$4.5B	$7.1B	$10.4B	$12.8B	$8.9B
Shares Outstanding	95M	98M	98M	98M	98M

Line Item	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3
Revenue	$11.8B	$11.8B	$12.0B	$12.5B	$12.8B	$12.9B	$12.7B	$12.7B
Cost of Revenue	$7.5B	$7.7B	$8.3B	$9.1B	$9.3B	$9.2B	$9.3B	$9.6B
Gross Profit	$4.3B	$4.0B	$3.7B	$3.5B	$3.6B	$3.7B	$3.4B	$3.1B
Gross Margin	36.4%	34.2%	30.8%	27.9%	27.8%	28.7%	26.5%	24.4%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$1.2B	$2.0B	$2.0B	$2.5B	$1.7B	$2.1B	$2.1B	$2.3B
Operating Expenses	$1.8B	$2.0B	$2.0B	$2.5B	$1.7B	$2.1B	$2.1B	$2.3B
Operating Income	$2.5B	$2.0B	$1.7B	$954M	$1.8B	$1.6B	$1.2B	$820M
Operating Margin	20.9%	17.1%	14.4%	7.6%	14.1%	12.4%	9.5%	6.5%
Interest Expense	$102M	$115M	$138M	$162M	$148M	$156M	$181M	$167M
Income Before Tax	$2.4B	$1.9B	$1.9B	$473M	$1.4B	$1.6B	$1.2B	$892M
Tax Expense	$708M	$562M	$562M	$162M	$739M	$494M	$418M	$303M
Net Income	$1.7B	$1.3B	$1.3B	$310M	$662M	$1.1B	$815M	$589M
Net Margin	14.4%	11.4%	11.1%	2.5%	5.2%	8.4%	6.4%	4.6%
EPS (Diluted)	$17.29	$13.78	$13.76	$3.18	$6.78	$11.08	$8.32	$6.00
EBITDA	$3.1B	$2.5B	$2.7B	$1.7B	$2.3B	$2.5B	$2.2B	$1.7B
Shares Outstanding	98M	98M	97M	98M	98M	98M	98M	98M

7071.T JPX